LivaNova (LIVN) EBITDA Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.00 |
| Dec 31, 2025 | -330.00 |
| Sep 30, 2025 | -27.00 |
| Jun 30, 2025 | 3.00 |
| Mar 31, 2025 | 384.00 |
| Dec 31, 2024 | 31.00 |
| Sep 30, 2024 | -141.00 |
| Jun 30, 2024 | 710.00 |
| Mar 31, 2024 | 3,388.00 |
| Dec 31, 2023 | -2,993.00 |
| Sep 30, 2023 | -435.00 |
| Jun 30, 2023 | 680.00 |
| Mar 31, 2023 | -597.00 |
| Dec 31, 2022 | 5,732.00 |
| Sep 30, 2022 | -6,474.00 |
| Jun 30, 2022 | 854.00 |
| Mar 31, 2022 | -521.00 |
| Dec 31, 2021 | 268.00 |
| Sep 30, 2021 | 2,020.00 |
| Jun 30, 2021 | -1,141.00 |
| Mar 31, 2021 | 9,008.00 |
| Dec 31, 2020 | -8,924.00 |
| Sep 30, 2020 | 604.00 |
| Jun 30, 2020 | -895.00 |
| Mar 31, 2020 | 4,982.00 |
| Dec 31, 2019 | -5,965.00 |
| Sep 30, 2019 | 2,037.00 |
| Jun 30, 2019 | -249.00 |
| Mar 31, 2019 | 8,480.00 |
| Dec 31, 2018 | -9,097.00 |
| Sep 30, 2018 | -963.00 |
| Jun 30, 2018 | 251.00 |
| Mar 31, 2018 | -180.00 |
| Dec 31, 2017 | -514.00 |
| Sep 30, 2017 | 109.00 |
| Jun 30, 2017 | 215.00 |
| Mar 31, 2017 | 1,466.00 |
| Dec 31, 2016 | -1,869.00 |
| Sep 30, 2016 | 279.00 |
| Jun 30, 2016 | 1,398.00 |
| Oct 18, 2015 | -6,527.00 |
| Jul 24, 2015 | 367.00 |